• 文档语言：英文
• 文档大小：28KB
• 文档类型：PPT
• 发布时间：2017/6/9 14:45:24
• 相关网站：internet
• 下载
• 版权说明：本站所有资源来源于网络，版权为原作者所有，本站刊载，仅限于促进医药行业发展、科技进步之目的。如本站行为侵犯了您的合法权益，请来信告知，我们将妥善处理。给您带来不便，敬请原谅。
• 幻灯介绍：

Stenting with or without Protection in High-Risk Patients with Moderate to High-Grade Carotid Stenosis
Presented at ACC 2003
Late Breaking Clinical Trials
ARCHER Trial
ARCHER
437 high-risk patients with moderate to high-grade carotid stenosis
>50% stenosis in symptomatic patients
>80% stenosis in asymptomatic patients
>1 co-morbid condition: >2 vessels with >70% stenosis; MI within 30 days; unstable angina; EF <30% or NYHA class >III; COPD; dialysis for chronic renal failure; uncontrolled diabetes; restenotic lesion after CEA
Treatment Group A
ACCULINK? Carotid Stent System
+
ACCUNET? Embolic Protection System
(n = 278)
Treatment Group B
ACCULINK? Carotid Stent System  without protection
(n = 159)
Endpoints:
Primary  – 30 day Death, Stroke or MI
ACC 2003 Late Breaking Trials
Death/
MI/
Stroke
ARCHER: 30 Day Event Rates
ACC 2003 Late Breaking Trials
Stroke
Death
MI